Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.
We visualized DNA topoisomerases in A431 cells and isolated chromosomes by isoenzyme-selective immunofluorescence microscopy. In interphase, topoisomerase I mainly had a homogeneous nuclear distribution. 10-15% of the cells exhibited granular patterns, 30% showed bright intranucleolar patches. Topoisomerase II isoenzymes showed spotted (alpha) or reticular (beta) nuclear patterns throughout interphase. In contrast to topoisomerase IIalpha, topoisomerase IIbeta was completely excluded from nucleoli. In mitosis, topoisomerase IIbeta diffused completely into the cytosol, whereas topoisomerases I and IIalpha remained chromosome bound. Chromosomal staining of topoisomerase I was homogeneous, whereas topoisomerase IIalpha accumulated in the long axes of the chromosome arms and in the centriols. Topoisomerase antigens were 2-3-fold higher in mitosis than in interphase, but specific activities of topoisomerase I and II were reduced 5- and 2.4-fold, respectively. These changes were associated with mitotic enzyme hyperphosphorylation. In interphase, topoisomerases could be completely linked to DNA by etoposide or camptothecin, whereas in mitosis, 50% of topoisomerase IIalpha escaped poisoning. Refractoriness to etoposide could be assigned to the salt-stable scaffold fraction of topoisomerase IIalpha, which increased from <2% in G1 phase to 48% in mitosis. Topoisomerases I and IIbeta remained completely extractable throughout the cell cycle. In summary, expression of topoisomerases increases towards mitosis, but specific activities decrease. Topoisomerase IIbeta is released from the heterochromatin, whereas topoisomerase I and IIalpha remain chromosome bound. Scaffold-associated topoisomerase IIalpha appears not to be involved in catalytic DNA turnover, though it may play a role in the replicational cycle of centriols, where it accumulates during M phase.
Meyer
K N
KN
Medizinische Poliklinik, University of Wurzburg, Germany.
Kjeldsen
E
E
Straub
T
T
Knudsen
B R
BR
Hickson
I D
ID
Kikuchi
A
A
Kreipe
H
H
Boege
F
F
D000918:Antibody Specificity; D002384:Catalysis; D002453:Cell Cycle / Q000235:genetics*; D002460:Cell Line; D002467:Cell Nucleus / Q000201:enzymology; D002877:Chromosomes, Human / Q000378:metabolism; D004264:DNA Topoisomerases, Type I / Q000276:immunology / Q000378:metabolism*; D004250:DNA Topoisomerases, Type II / Q000276:immunology / Q000378:metabolism* / Q000502:physiology; D004789:Enzyme Activation; D006801:Humans; D007399:Interphase; D008938:Mitosis; D010766:Phosphorylation
D004264:DNA Topoisomerases, Type I; D004250:DNA Topoisomerases, Type II